The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 18, 2017

Filed:

Jan. 30, 2015
Applicant:

Pioneer Surgical Technology, Inc., Marquette, MI (US);

Inventors:

Francis Vincent Lamberti, Cary, NC (US);

Richard Chris Klann, Washington, NC (US);

Ronald Stewart Hill, Greenville, NC (US);

Assignee:

RTI Surgical Technology, Inc., Marquette, MI (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 57/16 (2006.01); A61L 27/22 (2006.01); A61L 27/26 (2006.01); A61L 27/34 (2006.01); A61L 27/52 (2006.01); A61L 31/10 (2006.01); A61L 27/02 (2006.01); A61L 27/12 (2006.01); A61L 27/36 (2006.01); A61F 2/00 (2006.01); A61K 47/42 (2017.01); A61L 27/20 (2006.01); A61L 27/24 (2006.01); A61L 27/54 (2006.01); B29C 39/00 (2006.01); B29L 31/00 (2006.01);
U.S. Cl.
CPC ...
A61L 27/222 (2013.01); A61F 2/0063 (2013.01); A61K 47/42 (2013.01); A61L 27/025 (2013.01); A61L 27/12 (2013.01); A61L 27/20 (2013.01); A61L 27/22 (2013.01); A61L 27/24 (2013.01); A61L 27/26 (2013.01); A61L 27/34 (2013.01); A61L 27/3608 (2013.01); A61L 27/52 (2013.01); A61L 27/54 (2013.01); A61L 31/10 (2013.01); B29C 39/003 (2013.01); A61L 2300/112 (2013.01); A61L 2300/412 (2013.01); A61L 2430/02 (2013.01); B29L 2031/7532 (2013.01); Y10T 428/29 (2015.01); Y10T 428/2947 (2015.01); Y10T 428/31551 (2015.04); Y10T 428/31786 (2015.04);
Abstract

The present invention is directed to a stabilized cross-linked hydrogel matrix comprising a first high molecular weight component and a second high molecular weight component that are covalently linked, and at least one stabilizing or enhancing agent, wherein the first high molecular weight component and the second high molecular weight component are each selected from the group consisting of polyglycans and polypeptides. This stabilized hydrogel matrix may be prepared as bioactive gels, pastes, slurries, cell attachment scaffolds for implantable medical devices, and casting or binding materials suitable for the construction of medical devices. The intrinsic bioactivity of the hydrogel matrix makes it useful as a gel or paste in multiple applications, including as a cell attachment scaffold that promotes wound healing around an implanted device, as gels and pastes for induction of localized vasculogenesis, wound healing, tissue repair, and regeneration, as a wound adhesive, and for tissue bulking.


Find Patent Forward Citations

Loading…